The Indian Council of Medical Research has intensified its efforts to enhance availability of COVID-19 testing kits and newer innovative testing solutions amid the rising cases of coronavirus in India.
ICMR has proposed to exempt several reputed global agencies from validation criteria for RTPCR, RAT, home based testing solution, antigen, antibody ELISA and rapid antibody tests. It further proposed to accord marketing permission by Drugs Controller General of India on the basis of existing approvals.
Several global agencies of Europe, Japan, South Korea, Australia, Brazil and the agencies listed in the World Health Organization’s emergency use listing will benefit from this move.
At present, kits approved by the US Food and Drug Administration under regular or emergency use are exempted from validation in India. It qualifies for direct marketing permission from the Drug Controller General of India.
Support Ethical Journalism. Support The Dispatch
The Dispatch is a sincere effort in ethical journalism. Truth, Accuracy, Independence, Fairness, Impartiality, Humanity and Accountability are key elements of our editorial policy. But we are still not able to generate great stories, because we don’t have adequate resources. As more and more media falls into corporate and political control, informed citizens across the world are funding independent journalism initiatives. Here is your chance to support your local media startup and help independent journalism survive. Click the link below to make a payment of your choice and be a stakeholder in public spirited journalism